MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
Log in

ETR:SAEShop Apotheke Europe Stock Price, Forecast & News

€93.00
-2.10 (-2.21 %)
(As of 05/29/2020 10:55 AM ET)
Add
Compare
Today's Range
€91.80
Now: €93.00
€94.80
50-Day Range
€62.80
MA: €75.88
€102.40
52-Week Range
€28.30
Now: €93.00
€92.70
Volume63,882 shs
Average VolumeN/A
Market Capitalization$1.12 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, Belgium, the Netherlands, France, Italy, and Spain. It provides non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company was founded in 2001 and is headquartered in Venlo, the Netherlands.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical Retailers
Sub-IndustryN/A
SectorConsumer Defensive
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$701.01 million
Cash Flow€8.92 per share
Book Value€17.29 per share

Profitability

Miscellaneous

Employees843
Market Cap$1.12 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive SAE News and Ratings via Email

Sign-up to receive the latest news and ratings for SAE and its competitors with MarketBeat's FREE daily newsletter.

Shop Apotheke Europe (ETR:SAE) Frequently Asked Questions

How has Shop Apotheke Europe's stock been impacted by COVID-19 (Coronavirus)?

Shop Apotheke Europe's stock was trading at €44.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SAE shares have increased by 109.7% and is now trading at €93.00. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Shop Apotheke Europe?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shop Apotheke Europe in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Shop Apotheke Europe.

What price target have analysts set for SAE?

7 equities research analysts have issued 12 month target prices for Shop Apotheke Europe's shares. Their forecasts range from €68.00 to €140.00. On average, they expect Shop Apotheke Europe's stock price to reach €107.57 in the next twelve months. This suggests a possible upside of 15.7% from the stock's current price. View analysts' price targets for Shop Apotheke Europe.

Has Shop Apotheke Europe been receiving favorable news coverage?

News articles about SAE stock have been trending somewhat negative on Friday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Shop Apotheke Europe earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news aboutShop Apotheke Europe.

Who are some of Shop Apotheke Europe's key competitors?

What other stocks do shareholders of Shop Apotheke Europe own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shop Apotheke Europe investors own include Teladoc Health (TDOC), Sony (SNE), Cie Gnrl des Etblsmnts Michelin SCA (MGDDF) and Booking (BKNG).

Who are Shop Apotheke Europe's key executives?

Shop Apotheke Europe's management team includes the following people:
  • Mr. Stephan Weber, Co-Founder, Chief Marketing Officer, Deputy CEO & Member of the Managing Board (Age 40)
  • Mr. Marc Fischer, Co-Founder, CTO & Member of the Managing Board (Age 44)
  • Dr. Ulrich Wandel, CFO & Member of the Managing Board (Age 55)
  • Ms. Theresa Holler, COO & Member of the Managing Board (Age 46)
  • Mr. Michael Köhler, Consultant (Age 57)

What is Shop Apotheke Europe's stock symbol?

Shop Apotheke Europe trades on the ETR under the ticker symbol "SAE."

What is Shop Apotheke Europe's stock price today?

One share of SAE stock can currently be purchased for approximately €93.00.

How big of a company is Shop Apotheke Europe?

Shop Apotheke Europe has a market capitalization of $1.12 billion and generates $701.01 million in revenue each year. Shop Apotheke Europe employs 843 workers across the globe.

What is Shop Apotheke Europe's official website?

The official website for Shop Apotheke Europe is shop-apotheke-europe.com.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.